Discover what the stars have in store for you today! From career breakthroughs to relationship dynamics and health concerns, ...

Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsJennifer Halchak - VP, IRKevin Ali - ...

The writing committee says collaborative efforts and patient-level perspective can improve management of pain in this ...

It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2024. “In 2024 we achieved our third year of constant currency revenue growth and delivered ...

Organon & Co (OGN) reported its financial results for the fourth quarter of 2024, revealing stable revenue figures in line with forecasts and a slight miss on earnings per share (EPS). Despite this, ...

Recommendations are presented regarding the use of pharmacologic treatments for the prevention of episodic migraine headache ...

The National Medical Commission (NMC) has issued Guidelines for the competency-based postgraduate training programme for MCh ...